Skip to main content
Hit enter to search or ESC to close
Close Search
Mirus Capital Advisors | Logo | Middle-Market Investment Bank
search
Menu
  • Industry Focus
    • Technology
    • Industrial
    • Business Services
    • Healthcare & Life Sciences
    • Consumer
  • Services
    • M&A Advisory
    • Capital Advisory
    • Fairness Opinions & Valuations
  • Clients
  • Team
  • About
    • Message from Our Leadership
    • Transactions
    • Global Reach
    • Culture
    • Careers
    • News & Insights
  • Contact
  • search
  • Industry Focus
    • Technology
    • Industrial
    • Business Services
    • Healthcare & Life Sciences
    • Consumer
  • Services
    • M&A Advisory
    • Capital Advisory
    • Fairness Opinions & Valuations
  • Clients
  • Team
  • About
    • Message from Our Leadership
    • Transactions
    • Global Reach
    • Culture
    • Careers
    • News & Insights
  • Contact

News & Insights

Mirus Capital Advisors Advises Oxipit on Sale to Sectra | Mirus Capital Advisors | Investment Bank
Mirus Capital Advisors Advises Oxipit on its Sale to Sectra

Mirus Capital Advisors Advises Oxipit on its Sale to Sectra

Mirus Capital Advisors, one of New England’s largest independent middle-market investment banks, has advised Oxipit,…
Patti
PattiApril 20, 2026
Keensight Capital Acquires Majority Stake in Isto Biologics | A portfolio company of Thompston Street Capital Partners | Mirus Capital Advisors
Mirus Capital Advisors Serves as Financial Advisor to Keensight Capital on its Acquisition of a Majority Stake in Isto Biologics

Mirus Capital Advisors Serves as Financial Advisor to Keensight Capital on its Acquisition of a Majority Stake in Isto Biologics

Mirus Capital Advisors, Inc., a leading independent middle-market investment banking firm, is pleased to announce…
pagano
paganoSeptember 18, 2025
Softlinx has been aquired by Valsoft | Miurs Capital Advisors | Investment Bank
Mirus Capital Advisors advises Softlinx on its sale to Valsoft

Mirus Capital Advisors advises Softlinx on its sale to Valsoft

Mirus Capital Advisors, Inc., one of the largest independent middle-market investment banking firms in New…
pagano
paganoFebruary 20, 2025
Mirus Capital Advisors provided a fairness opinion to the Special Committee of Psychemedics Corp.
Mirus Capital Advisors Provides Fairness Opinion to Psychemedics Corp.

Mirus Capital Advisors Provides Fairness Opinion to Psychemedics Corp.

Mirus Capital Advisors provided a fairness opinion to the Special Committee of Psychemedics Corp. Transaction…
Patti
PattiAugust 28, 2024
Applied Biomath has been acquired by Certara | Mirus Capital Advisors | Middle Market Investment Bank
Mirus advises Applied BioMath on acquisition by Certara (Nasdaq:CERT)

Mirus advises Applied BioMath on acquisition by Certara (Nasdaq:CERT)

Certara Acquires Applied Biomath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing…
pagano
paganoDecember 14, 2023
JACO acquired by GCX Mounting Solutions, a portfolio company of Audax Private Equity | Mirus Capital Advisors | Premier Middle Market Investment Bank
Mirus represents Jaco in transaction with GCX

Mirus represents Jaco in transaction with GCX

Acquisition Augments GCX’s Line of High-Quality Mounting Solutions PETALUMA, Calif.–(BUSINESS WIRE)–GCX Mounting Solutions (“GCX”), a…
pagano
paganoDecember 9, 2022
Syrinx acquired by De Winter Group, a portfolio company of New Heritage Capital | Mirus Capital Advisors | Top Middle Market Investment Bank
Mirus represents Syrinx Consulting in transaction with DeWinter Group

Mirus represents Syrinx Consulting in transaction with DeWinter Group

CAMPBELL, Calif.--DeWinter Group (“DeWinter”), a Silicon Valley-based provider of finance & accounting and technology staffing…
pagano
paganoOctober 14, 2022
TheraCell acquired by Isto Biologics a portfolio company of Thompson Street Capital Partners | Mirus Capital Advisors | Healthcare Investment Bankers
Mirus Advises TheraCell on its Sale to Isto Biologics

Mirus Advises TheraCell on its Sale to Isto Biologics

Mirus Capital Advisors is pleased to announce that it served as the exclusive financial advisor…
pagano
paganoApril 7, 2022
Mirus Capital Advisors provided a fairness opinion to EyeGate Pharma for the acquisition of Panoptes Pharma
Mirus Capital Advisors Provides Fairness Opinion to EyeGate Pharma

Mirus Capital Advisors Provides Fairness Opinion to EyeGate Pharma

Mirus Capital Advisors provided a fairness opinion to EyeGate Pharma for the acquisition of Panoptes…
Patti
PattiDecember 21, 2020
AdvanSource Biomaterials sold its assets to mcpp, a company of Mitsubishi Chemical | Mirus Capital Advisors | Top Investment Bank
Mirus Client AdvanSource Biomaterials Corporation Completes the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

Mirus Client AdvanSource Biomaterials Corporation Completes the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

Burlington, MA – Mirus Capital Advisors announced today that it acted as the exclusive financial…
pagano
paganoFebruary 10, 2020
  • 1
  • 2
  • 3
  • 4
  • Next
Mirus Capital Advisors | White Logo | Middle-Market Investment Bank

Mirus Capital Advisors is the parent company of Mirus Securities Inc.

Mirus Securities Inc. is a member of FINRA and SIPC. Check the background of this firm in FINRA’s BrokerCheck.

Contact

200 Summit Drive
4th Floor South
Burlington, MA 01803

Phone Icon | Mirus Capital Advisors
781.418.5900
Email Icon | Mirus Capital Advisors
781.418.5999
Envelope Icon | Mirus Capital Advisors
info@merger.com
Recent News

June 2026 Middle Market Monitor

Patti | Featured Report | No Comments
Each month at Mirus, we dig into the data that's shaping the middle market landscape. Our June 2026 Mirus Middle Market Monitor provides a snapshot of key economic metrics and…

Medical Devices Report: Q1 2026

Patti | Featured Report, Healthcare & Life Sciences, Healthcare Equipment, MedTech | No Comments
An in-depth look at the Q1 2026 Medical Device sector, where Mirus' partners apply their expertise and experience to take a closer look at news, transactions, and state of the…
Downloads

About Mirus

Stay In Touch

Subscribe to our News & Insights

©2026 Mirus Capital Advisors. All Rights Reserved. Privacy Policy. Business Continuity Plan. Cookie Policy.

Manage Consent

Manage Consent | By using this website, you agree to our use of cookies to enable essential site functionality and perform analytics. You may opt-out by clicking on Cookie Policy

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}